{
    "id": "0796",
    "question": "While traveling abroad a physician is asked to attend a meeting regarding healthcare in the region. The rate of chlamydial infection is exceptionally high in the area, and the local government is wanting to test a new treatment for these infections. To test the new therapy, the physician is asked to oversee the operations of testing this new treatment. When asking what this would entail, the officials tell the physician that they plan to infect the local prison population with chlamydia and then test the new treatment on these individuals. Which of the following is the best response from the physician?",
    "options": {
        "A": "\u201cI can not help you due to the ethical principle of autonomy.\u201d",
        "B": "\u201cI can not help you due to the ethical principle of justice.\u201d",
        "C": "\u201cI can not help you due to the ethical principle of nonmaleficence.\u201d",
        "D": "\u201cI can not help you due to the ethical principle of beneficence.\u201d"
    },
    "answer": "C",
    "predict": "Here's the step-by-step thinking and the final answer in JSON format: ```json { \"step_by_step_thinking\": \"The question requires the physician to consider the ethical principles of autonomy, nonmaleficence, beneficence, and justice in the context of a public health experiment involving infecting a prison population with chlamydia to test a new treatment. The physician must weigh the potential benefits of the treatment against the potential harm to the prisoners and the ethical implications of such an experiment. The physician should consider the principles of autonomy, nonmaleficence, and beneficence to determine the best course of action. Autonomy is not directly relevant in this scenario as the physician is being asked to participate in a government-mandated experiment. Nonmaleficence is relevant as the physician must consider the potential harm to the prisoners. Beneficence is also relevant as the physician must consider the potential benefits of the treatment to the prisoners. However, the primary ethical principle at play is justice, as the physician is being asked to participate in an experiment that may disproportionately affect a vulnerable population (prisoners). The physician should refuse to participate in the experiment due to the potential for harm to the prisoners and the lack of informed consent.\", \"answer_choice\": \"B\" } ``` The best answer is B. The physician should refuse to participate in the experiment due to the potential harm to the prisoners and the lack of informed consent. This decision is guided by the ethical principle of justice, which requires that individuals not be subjected to harm or exploitation without their consent. While the physician may also consider the principles of nonmaleficence and beneficence, the primary concern in this scenario is the potential harm to the prisoners.",
    "snippets": [
        {
            "id": "InternalMed_Harrison_10890",
            "title": "InternalMed_Harrison",
            "content": "Persons with a new-onset STI always have a source contact who gave them the infection; in addition, they may have a secondary (spread or exposed) contact with whom they had sex after becoming infected. The identification and treatment of these two types of contacts have different objectives. Treatment of the source contact (often a casual contact) benefits the community by preventing further transmission and benefits the source contact; treatment of the recently exposed secondary contact (typically a spouse or another steady sexual partner) prevents the development of serious complications (such as PID) in the partner, reinfection of the index patient, and further spread of infection. A survey of a random sample of U.S. physicians found that most instructed patients to abstain from sex during treatment, to use condoms, and to inform their sex partners after being diagnosed with gonorrhea, chlamydial infection, or syphilis; physicians sometimes gave the patients drugs for their"
        },
        {
            "id": "InternalMed_Harrison_14094",
            "title": "InternalMed_Harrison",
            "content": "Prevention Since many chlamydial infections are asymptomatic, effective control and prevention must involve periodic screening of individuals at risk. Selective cost-effective screening criteria have been developed. Among women, young age (generally <25 years) is a critical risk factor for chlamydial infections in nearly all studies. Other risk factors include mucopurulent cervicitis; multiple, new, or symptomatic male sex partners; and lack of barrier contraceptive use. In some settings, screening based on young age may be as sensitive 1172 as criteria that incorporate behavioral and clinical measures. Another strategy is universal testing of all patients in high-prevalence clinic populations (e.g., STD clinics, juvenile detention facilities, and family planning clinics). The effectiveness of selective screening in reducing the prevalence of chlamydial infection among women has been demonstrated in several studies. In the Pacific Northwest, where extensive screening began in family"
        },
        {
            "id": "InternalMed_Harrison_9904",
            "title": "InternalMed_Harrison",
            "content": "Several countries routinely deny entry to HIV-positive individuals for prolonged stay, even though these restrictions do not appear to decrease rates of transmission of the virus. In general, HIV testing is required for individuals who wish to stay abroad >3 months or who intend to work or study abroad. Some countries will accept an HIV serologic test done within 6 months of departure, whereas others will not accept a blood test done at any time in the traveler\u2019s home country. Border officials often have the authority to make inquiries of individuals entering a country and to check the medications they are carrying. If antiretroviral drugs are identified, the person may be barred from entering the country. Information on testing requirements for specific countries is available from consular offices but is subject to frequent change."
        },
        {
            "id": "InternalMed_Harrison_14092",
            "title": "InternalMed_Harrison",
            "content": "The continued high prevalence of chlamydial infections in most parts of the United States is due primarily to the failure to diagnose\u2014and therefore treat\u2014patients with symptomatic or asymptomatic infection and their sex partners. Urethral or cervical infection with C. trachomatis has been well documented in a high proportion of the sex partners of patients with NGU, epididymitis, reactive arthritis, salpingitis, and endocervicitis. If possible, confirmatory laboratory tests for chlamydiae should be undertaken in these individuals, but even those without positive tests or evidence of clinical disease who have recently been exposed to proven or possible chlamydial infection (e.g., NGU) should be offered therapy. A novel approach is partner-delivered therapy, in which infected patients receive treatment and are also provided with single-dose azithromycin to give to their sex partner(s)."
        },
        {
            "id": "InternalMed_Harrison_10889",
            "title": "InternalMed_Harrison",
            "content": "the clinician must encourage patients to participate in partner notification, must ensure that exposed persons are notified and treated, and must guarantee confidentiality to all involved. In the United States, local health departments often offer assistance in partner notification, treatment, and/or counseling. It seems both feasible and most useful to notify those partners exposed within the patient\u2019s likely period of infectiousness, which is often considered the preceding 1 month for gonorrhea, 1\u20132 months for chlamydial infection, and up to 3 months for early syphilis."
        },
        {
            "id": "InternalMed_Harrison_14096",
            "title": "InternalMed_Harrison",
            "content": "screening becomes more cost-effective than universal screening must be defined. Most studies have concluded that universal screening is preferable in settings with a chlamydial prevalence of >3\u20137%. Depending on the criteria used, selective screening is likely to be more cost-effective when prevalence falls below 3%. Nearly all regions of the United States have now initiated screening programs, particularly in family planning and STD clinics. Along with single-dose therapy, the availability of highly sensitive and specific diagnostic NAATs using urine specimens and self-obtained vaginal swabs makes it feasible to mount an effective nationwide Chlamydia control program, with screening of high-risk individuals in traditional health-care settings and in novel outreach and community-based settings. The"
        },
        {
            "id": "InternalMed_Harrison_10819",
            "title": "InternalMed_Harrison",
            "content": "Although the above criteria for MPC are neither highly specific nor highly predictive of gonococcal or chlamydial infection in some settings, the 2010 CDC STD guidelines call for consideration of empirical treatment for MPC, pending test results, in most patients. Presumptive treatment with antibiotics active against C. trachomatis should be provided for women at increased risk for this common STI (risk factors: age <25 years, new or multiple sex partners, and unprotected sex), especially if follow-up cannot be ensured. Concurrent therapy for gonorrhea is indicated if the prevalence of this infection is substantial in the relevant patient population (e.g., young adults, a clinic with documented high prevalence). In this situation, therapy should include a single-dose regimen effective for gonorrhea plus treatment for chlamydial infection, as outlined in Table 163-4 for the treatment of urethritis. In settings where gonorrhea is much less common than chlamydial infection, initial"
        },
        {
            "id": "InternalMed_Harrison_10891",
            "title": "InternalMed_Harrison",
            "content": "sex during treatment, to use condoms, and to inform their sex partners after being diagnosed with gonorrhea, chlamydial infection, or syphilis; physicians sometimes gave the patients drugs for their partners. However, follow-up of the partners by physicians was infrequent. A randomized trial compared patients\u2019 delivery of therapy to partners exposed to gonorrhea or chlamydial infection with conventional notification and advice to partners to seek evaluation for 883 STD; patients\u2019 delivery of partners\u2019 therapy, also known as expedited partner therapy (EPT), significantly reduced combined rates of reinfection of the index patient with N. gonorrhoeae or C. trachomatis. State-by-state variations in regulations governing this approach have not been well defined, but the 2010 CDC STD treatment guidelines and the EPT final report of 2006 (http://www.cdc.gov/std/treatment/ EPTFinalReport2006.pdf) describe its potential use. Currently, EPT is commonly used by many practicing physicians. Its"
        },
        {
            "id": "Obstentrics_Williams_8994",
            "title": "Obstentrics_Williams",
            "content": "Pregnant women who live in high-prevalence areas or who are at risk for gonorrhea should undergo irst-trimester screening. Risk factors include age \ufffd25 years; prior gonococcal infection; other STDs; prostitution; new or multiple sexual partners; drug abuse; black, Hispanic, or American Indian or laska Native ethnicity; and inconsistent condom use (American Academy of Pediatrics, 2017). For women who test positive, screening for syphilis, chlamydial infection, and HIV should precede treatment, if possible. Gonococcal infection is a marker for concomitant chlamydial infection. Thus, if chlamydial testing is unavailable, presumptive chlamydial therapy is given to women treated for gonorrhea."
        },
        {
            "id": "InternalMed_Harrison_15443",
            "title": "InternalMed_Harrison",
            "content": "Education, counseling, and behavior modification are the cornerstones of any HIV prevention strategy. A major problem in the United States and elsewhere is that many infections are passed on by those who do not know that they are infected. Of the ~1.1 million persons in the United States who are HIV-infected, it is estimated that ~16\u201318% do not know their HIV status and approximately 49% of all new infections are transmitted by those people who are not aware that they are infected. In this regard, the CDC has recommended that HIV testing become part of routine medical care and that all individuals between the ages of 13 and 64 years be tested at least one time. These individuals should be informed of the testing and be tested without the need for written informed consent. Each individual could \u201copt out\u201d of testing, but testing would otherwise be routinely administered. Individuals who are practicing high-risk behavior should be tested more often. In addition to identifying individuals"
        },
        {
            "id": "InternalMed_Harrison_9929",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 149-2 Proportionate morbidity among ill travelers returning from the developing world, according to region of travel. The proportions (not incidence rates) are shown for each of the top 22 specific diagnoses among all ill returned travelers within each region. STDs, sexually transmitted diseases. Asterisks indicate syndromic diagnoses for which specific etiologies could not be assigned. (Reprinted from DO Freedman et al: N Engl J Med 354:119, 2006.) some travelers who have been hospitalized abroad have been shown on return to be colonized with multidrug-resistant bacteria such as Enterobacteriaceae producing extended-spectrum \u03b2-lactamases and bacteria producing NDM-1 (New Delhi metallo-\u03b2-lactamase 1). See \u201cPrevention of Gastrointestinal Illness,\u201d above."
        },
        {
            "id": "InternalMed_Harrison_14041",
            "title": "InternalMed_Harrison",
            "content": "In the United States, chlamydial infections are the most commonly reported of all infectious diseases. In 2012, 1.3 million cases were reported to the U.S. Centers for Disease Control and Prevention (CDC); however, the CDC estimates that 2\u20133 million new cases occur per year, with substantial underreporting due to lack of screening in some populations. Rates of infection have increased every year; higher rates among women than among men reflect the focus on expansion of screening programs for women during the past 20 years, the use of increasingly sensitive diagnostic tests, an increased emphasis on case reporting, and improvements in the information systems used for reporting. The CDC and other professional organizations recommend annual screening of all sexually active women \u226425 years of age as well as rescreening of previously infected individuals at 3 months. Young women have the highest infection rates; in 2012, the figures were 3416.5 and 3722.5 cases per 100,000 population at"
        },
        {
            "id": "InternalMed_Harrison_9921",
            "title": "InternalMed_Harrison",
            "content": "Today, more elderly or chronically ill individuals travel and more of these individuals journey to remote locations and enjoy adventurous activities. Illness or injury abroad is not uncommon and is best considered before the journey. Persons who develop health problems abroad may incur enormous out-of-pocket expenses. Thus prospective travelers should consider purchasing additional travel health insurance and 799 should check with their health insurance company regarding whether they have coverage for illness or injury overseas. Unfortunately, many insurance companies will not cover pre-existing illness if it is the reason for trip cancellation or illness abroad. Most countries do not accept routine health insurance from other countries unless there is a special traveler supplement. In most circumstances, travelers are asked to pay in cash for services rendered on an emergency basis, whether in a physician\u2019s office, in an emergency or urgent care center, or even in a hospital. There"
        },
        {
            "id": "InternalMed_Harrison_10752",
            "title": "InternalMed_Harrison",
            "content": "In the United States, the Centers for Disease Control and Prevention (CDC) has compiled reported rates of STIs since 1941. The incidence of reported gonorrhea peaked at 468 cases per 100,000 population in the mid-1970s and fell to a low of 98 cases per 100,000 in 2012. With increased testing and more sensitive tests, the incidence of reported Chlamydia trachomatis infection has been increasing steadily since reporting began in 1984, reaching an all-time peak of 457.6 cases per 100,000 in 2011. The incidence of primary and secondary syphilis per 100,000 peaked at 71 cases in 1946, fell rapidly to 3.9 cases in 1956, ranged from ~10 to 15 cases through 1987 (with markedly increased"
        },
        {
            "id": "InternalMed_Harrison_1221",
            "title": "InternalMed_Harrison",
            "content": "With the growing importance of and interest in global health, ods. Typically, physicians gain valuable experience while providing service to patients in need. Such arrangements, however, can raise ethical challenges\u2014for example, because of differences in beliefs 17e-3 about health and illness, expectations regarding health care and the physician\u2019s role, standards of clinical practice, and norms for disclosure of serious diagnoses. Additional dilemmas arise if visiting physicians take on responsibilities beyond their level of training or if donated drugs and equipment are not appropriate to local needs. Visiting physicians and trainees should exercise due diligence in obtaining needed information about the cultural and clinical practices in the host community, should work closely with local professionals and team members, and should be explicit about their skills, knowledge, and limits. In addition, these arrangements can pose risks. The visiting physician may face personal risk from"
        },
        {
            "id": "InternalMed_Harrison_12182",
            "title": "InternalMed_Harrison",
            "content": "Gonorrhea predominantly affects young, nonwhite, unmarried, less educated members of urban populations. The number of reported cases probably represents half of the true number of cases\u2014a discrepancy resulting from underreporting, self-treatment, and nonspecific treatment without a laboratory-proven diagnosis. The number of reported new cases of gonorrhea in the United States rose from ~250,000 in the early 1960s to a high of 1.01 million in 1978. The recorded incidence of gonorrhea in modern times peaked in 1975, with 468 reported new cases per 100,000 population in the United States. This peak was attributable to the interaction of several variables, including improved accuracy of diagnosis, changes in patterns of contraceptive use, and changes in sexual behavior. The incidence of the disease has since declined gradually and is currently estimated at 120 cases per 100,000, a figure that is still the highest among industrialized countries. A fur-1003 ther decline in the overall"
        },
        {
            "id": "InternalMed_Harrison_14095",
            "title": "InternalMed_Harrison",
            "content": "of selective screening in reducing the prevalence of chlamydial infection among women has been demonstrated in several studies. In the Pacific Northwest, where extensive screening began in family planning clinics in 1998 and in STD clinics in 1993, the prevalence declined from 10% in the 1980s to <5% in 2000. Similar trends have occurred in association with screening programs elsewhere. In addition, screening can effect a reduction in upper genital tract disease. In Seattle, women at a large health maintenance organization who were screened for chlamydial infection on a routine basis had a lower incidence of symptomatic PID than did women who received standard care and underwent more selective screening. In settings with low to moderate prevalence, the prevalence at which selective screening becomes more cost-effective than universal screening must be defined. Most studies have concluded that universal screening is preferable in settings with a chlamydial prevalence of >3\u20137%."
        },
        {
            "id": "First_Aid_Step1_270",
            "title": "First_Aid_Step1",
            "content": "Suicidal/homicidal patients. Abuse (children, elderly, and/or prisoners). Duty to protect\u2014state-specific laws that sometimes allow physician to inform or somehow protect potential Victim from harm. Epileptic patients and other impaired automobile drivers. Reportable Diseases (eg, STIs, hepatitis, food poisoning); physicians may have a duty to warn public officials, who will then notify people at risk. Dangerous communicable diseases, such as TB or Ebola, may require involuntary treatment. Patient is not adherent. Attempt to identify the reason for nonadherence and determine his/her willingness to change; do not coerce the patient into adhering and do not refer him/her to another physician. A patient\u2019s family member asks you not to disclose the results of a test if the prognosis is poor because the patient will be \u201cunable to handle it.\u201d"
        },
        {
            "id": "InternalMed_Harrison_10765",
            "title": "InternalMed_Harrison",
            "content": "Has your sex partner had other sex partners during the time you\u2019ve been together? STD Symptoms Checklist: (9) Have you recently developed any of these symptoms? Sexual Practices, Past 2 Months (for patients answering yes to any of the above questions, to guide examination and testing): Now I\u2019d like to ask what parts of your body may have been sexually exposed to an STD (e.g., your penis, mouth, vagina, anus). Query about Interest in STD Screening Tests (for patients answering no to all of the above questions): Would you like to be tested for HIV or any other STDs today? (If yes, clinician can explore which STD and why.) Source: Adapted from JR Curtis, KK Holmes, in KK Holmes et al (eds): Sexually Transmitted Diseases, 4th ed. New York, McGraw-Hill, 2008. Chlamydia-negative cases. Fewer studies than in the past have implicated Ureaplasma; the ureaplasmas have been differentiated into U. urealyticum and Ureaplasma parvum, and a few studies suggest that"
        },
        {
            "id": "InternalMed_Harrison_10880",
            "title": "InternalMed_Harrison",
            "content": "Because many infected individuals develop no symptoms or fail to recognize and report symptoms, clinicians should routinely perform an STI risk assessment for teenagers and young adults as a guide to selective screening. As stated earlier, U.S. Preventive Services Task Force Guidelines recommend screening sexually active female patients \u226425 years of age for C. trachomatis whenever they present for health care (at least once a year); older women should be tested if they have more than one sexual partner, have begun a new sexual relationship since the previous test, or have another STI diagnosed. In women 25\u201329 years of age, chlamydial infection is uncommon but still may reach a prevalence of 3\u20135% in some settings; information provided by women in this age group on a sex partner\u2019s concurrency (whether a male partner has had another sex partner during the time they have been together) is helpful in identifying women at increased risk. In some regions of the United States, widespread"
        },
        {
            "id": "InternalMed_Harrison_10757",
            "title": "InternalMed_Harrison",
            "content": "(e.g., gender, age, area of residence) is a simple first step in STD/HIV risk assessment. For example, national guidelines strongly recommend routine screening of sexually active females \u226425 years of age for C. trachomatis infection. Table 163-3 provides a set of 11 STD/HIV risk-assessment questions that clinicians can pose verbally or that health care systems can adapt (with yes/no responses) into a routine self-administered questionnaire for use in clinics. The initial framing statement gives permission to discuss topics that may be perceived as sensitive or socially unacceptable by providers and patients alike."
        },
        {
            "id": "InternalMed_Harrison_10852",
            "title": "InternalMed_Harrison",
            "content": "Prevention A randomized controlled trial designed to determine whether selective screening for chlamydial infection reduces the risk of subsequent PID showed that women randomized to undergo screening had a 56% lower rate of PID over the following year than did women receiving the usual care without screening. This report helped prompt U.S. national guidelines for risk-based chlamydial screening of young women to reduce the incidence of PID and the prevalence of post-PID sequelae, while also reducing sexual transmission of C. trachomatis. The CDC and the U.S. Preventive Services Task Force recommend that sexually active women \u226425 years of age be screened for genital chlamydial infection annually. Despite this recommenda-879 tion, screening coverage in many primary care settings remains low."
        },
        {
            "id": "InternalMed_Harrison_14042",
            "title": "InternalMed_Harrison",
            "content": "of age as well as rescreening of previously infected individuals at 3 months. Young women have the highest infection rates; in 2012, the figures were 3416.5 and 3722.5 cases per 100,000 population at 15\u201319 and 20\u201324 years of age, respectively. Age-specific rates among men, while much lower than those among women, were highest in the 20-to 24-year-old age group, at 1343.3 cases per 100,000. In 2012, rates 1167 increased for all racial and ethnic groups, with the highest rates among African Americans. For example, the rate of chlamydial infection among African-American girls 15\u201319 years of age was 7507.1 cases per 100,000\u2014almost six times the rate among Caucasian girls in the same age group (1301.5/100,000). The rate among African-American women 20\u201324 years old was 4.8 times the rate among Caucasian women in the same age group. Similar racial disparities in reported rates of chlamydial infection exist among men. For boys 15\u201319 years of age, the rate among African Americans was 11.1"
        },
        {
            "id": "InternalMed_Harrison_14097",
            "title": "InternalMed_Harrison",
            "content": "U.S. Preventive Services Task Force has given C. trachomatis screening a Grade A recommendation, which means that private insurance and Medicare will cover its cost under the Affordable Care Act. TRACHOMA Epidemiology Trachoma\u2014a sequela of ocular disease in developing countries\u2014continues to be a leading cause of preventable infectious blindness worldwide. The WHO estimates that ~6 million people have been blinded by trachoma and that ~1.3 million people in developing countries still suffer from preventable blindness due to trachoma; certainly hundreds of millions live in trachoma-endemic areas. Foci of trachoma persist in Australia, the South Pacific, and Latin America. Serovars A, B, Ba, and C are isolated from patients with clinical trachoma in areas of endemicity in developing countries in Africa, the Middle East, Asia, and South America."
        },
        {
            "id": "InternalMed_Harrison_15362",
            "title": "InternalMed_Harrison",
            "content": "whom the patient knows or suspects may also be infected. Once these baseline activities are performed, shortand long-term medical management strategies should be developed based on the most recent information available and modified as new information becomes available. The field of HIV medicine is changing rapidly, and it is difficult to remain fully up to date. Fortunately there are a series of excellent sites on the Internet that are frequently updated, and they provide the most recent information on a variety of topics, including consensus panel reports on treatment (Table 226-20)."
        },
        {
            "id": "InternalMed_Harrison_14044",
            "title": "InternalMed_Harrison",
            "content": "The above statistics are based on case reporting. Studies based on screening surveys estimate that the U.S. prevalence of C. trachomatis cervical infection is 5% among asymptomatic female college students and prenatal patients, >10% among women seen in family planning clinics, and >20% among women seen in STD clinics. The prevalence of genital C. trachomatis infections varies substantially by geographic locale, with the highest rates in the southeastern United States. However, asymptomatic infections have been detected in >8\u201310% of young female military recruits from all parts of the country. The prevalence of C. trachomatis in the cervix of pregnant women is 5\u201310 times higher than that of Neisseria gonorrhoeae. The prevalence of genital infection with either agent is highest among women who are between the ages of 18 and 24, single, and non-Caucasian (e.g., African-American, Latina, Asian, Pacific Islander). Infections recur frequently in these same risk groups and are often acquired"
        },
        {
            "id": "Anatomy_Gray_1266",
            "title": "Anatomy_Gray",
            "content": "The physician asked further questions. It is always important to establish whether the patient is pregnant (occasionally, pregnancy may come as a surprise to the patient). This patient\u2019s pregnancy test was negative. After the patient emptied her bladder, there was no change in the mass. The physician thought the mass might be a common benign tumor of the uterus (fibroid). To establish the diagnosis, he obtained an ultrasound scan of the pelvis, which confirmed that the mass stemmed from the uterus. The patient was referred to a gynecologist, and after a long discussion regarding her symptomatology, fertility, and risks, the surgeon and the patient agreed that a hysterectomy (surgical removal of the uterus) would be an appropriate course of therapy. The patient sought a series of opinions from other gynecologists, all of whom agreed that surgery was the appropriate option. The fibroid was removed with no complications."
        },
        {
            "id": "Pharmacology_Katzung_5610",
            "title": "Pharmacology_Katzung",
            "content": "D. Determine the Necessity for Empiric Therapy Whether to initiate empiric therapy is an important clinical decision based partly on experience and partly on data from clinical trials. Empiric therapy is indicated when there is a significant risk of serious morbidity or mortality if therapy is withheld until a specific pathogen is detected by the clinical laboratory. In other settings, empiric therapy may be indicated for public health reasons rather than for demonstrated superior outcome of therapy in a specific patient. For example, urethritis in a young sexually active man usually requires treatment for N gonorrhoeae and Chlamydia trachomatis despite the absence of microbiologic confirmation at the time of diagnosis. Because the risk of noncompliance with follow-up visits in this patient population may lead to further transmission of these sexually transmitted pathogens, empiric therapy is warranted. E. Institute Treatment"
        },
        {
            "id": "InternalMed_Harrison_9874",
            "title": "InternalMed_Harrison",
            "content": "Long-stay overseas workers appear to be at considerable risk for hepatitis B infection (Chap. 360). The recommendation that all travelers be immunized against hepatitis B before departure is supported by two studies showing that 17% of the assessed travelers who received health care abroad had some type of injection; according to the World Health Organization, nonsterile equipment is used for up to 75% of all injections given in parts of the developing world. A 3-week accelerated schedule of the combined hepatitis A and B vaccine has been approved in the United States. Although no data are available on the specific risk of infection with hepatitis B virus among U.S. travelers, ~240 million people in the world have chronic infection. All children and adolescents in the United States are immunized against this illness. Hepatitis B vaccination should be considered for all travelers."
        },
        {
            "id": "InternalMed_Harrison_1161",
            "title": "InternalMed_Harrison",
            "content": "On the basis of historic factors such as discrimination, segregation, and medical experimentation, blacks may be especially mistrustful of providers. The exploitation of blacks by the U.S. Public Health Service during the Tuskegee syphilis study from 1932 to 1972 left a legacy of mistrust that persists even today among this population. Other populations, including Native Americans/Alaskan Natives, Hispanics/ Latinos, and Asian Americans, also harbor significant mistrust of the health care system. A national Kaiser Family Foundation survey of 3884 individuals found that 36% of Hispanics and 35% of blacks (compared with 15% of whites) felt they had been treated unfairly in the health care system in the past because of their race/ethnicity. Perhaps even more alarming, 65% of blacks and 58% of Hispanics (compared with 22% of whites) were afraid of being treated unfairly in the future on that basis (Fig. 16e-8)."
        },
        {
            "id": "InternalMed_Harrison_9924",
            "title": "InternalMed_Harrison",
            "content": "Travel for the purpose of obtaining health care abroad has received a great deal of attention in the medical literature and the media. According to the annual U.S. Department of Commerce In-Flight Survey, there were ~500,000 overseas trips during 2006 in which health treatment was at least one purpose of travel. Lower cost is usually cited as the motivation for this type of tourism, and an entire industry has flourished as a result of this phenomenon. However, the quality of facilities, assistance services, and care is neither uniform nor regulated; thus, in most instances, responsibility for assessing the suitability of an individual program or facility lies solely with the traveler. Persons considering this option must recognize that they are almost always at a disadvantage when being treated in a foreign country, particularly if there are complications. Concerns to be addressed include the quality of the health care facility and its staff; language and cultural differences that may"
        },
        {
            "id": "InternalMed_Harrison_10881",
            "title": "InternalMed_Harrison",
            "content": "(whether a male partner has had another sex partner during the time they have been together) is helpful in identifying women at increased risk. In some regions of the United States, widespread selective screening and treatment of young women for cervical C. trachomatis infection have been associated with a 50\u201360% drop in prevalence. Such screening and treatment also protect the individual woman from PID. Sensitive urine-based genetic amplification tests permit expansion of screening to men, teenage boys, and girls in settings where examination is not planned or is impractical (e.g., during preparticipation sports examinations or during initial medical evaluation of adolescent girls). Vaginal swabs\u2014collected either by the health care provider at a pelvic examination or by the woman herself\u2014are highly sensitive and specific for the diagnosis of chlamydial and gonococcal infection; they are now the preferred type of specimen for screening and diagnosis of these infections."
        }
    ],
    "scores": [
        0.03605430988798129,
        0.031106627976568615,
        0.02850838481906443,
        0.027915633379705235,
        0.026152513587845386,
        0.02547822547822548,
        0.025255374040859847,
        0.025172863001225163,
        0.023106569984618765,
        0.02206119162640902,
        0.021684855952590506,
        0.019049346879535557,
        0.018957771787960466,
        0.017973200673995025,
        0.017345794392523366,
        0.017261904761904763,
        0.017174311926605505,
        0.017050298380221655,
        0.016802587176602924,
        0.01677018633540373,
        0.016606642657062826,
        0.01654003899683991,
        0.016203703703703703,
        0.01602077001013171,
        0.015988601082533943,
        0.015847665847665848,
        0.01575757575757576,
        0.015720418404982162,
        0.015444245676803817,
        0.015407319952774497,
        0.015205627705627707,
        0.015156714710592541
    ]
}